Multifaceted neuroprotective effects of (-)-epigallocatechin-3-gallate (EGCG) in Alzheimer’s disease: an overview of pre-clinical studies focused on β-amyloid peptide
ABSTRACT: Alzheimer’s disease (AD) is the most common neurodegenerative disease characterized by cognitive decline and memory impairment. Many lines of evidence indicate that excessive β-amyloid peptide (Aβ) generation and aggregation play pivotal roles in the initiation of AD, leading to various bi...
Saved in:
Main Authors: | Kumju Youn, Chi-Tang Ho, Mira Jun |
---|---|
Format: | Article |
Language: | English |
Published: |
Tsinghua University Press
2022-05-01
|
Series: | Food Science and Human Wellness |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2213453021001348 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effect of epigallocatechin-3-gallate (EGCG) on cognitive functioning and the expression of APP and BDNF in the hippocampus of rats with streptozotocin -induced Alzheimer-like disease
by: Farnaz Ghayour Babaei, et al.
Published: (2025-03-01) -
Neuroprotective role of epigallocatechin-3-gallate, albeginin and melanoxetin in alzheimer's disease
by: Arif Malik, et al.
Published: (2025-02-01) -
Degradation of amyloid β-peptides catalyzed by nattokinase in vivo and in vitro
by: Aixin Ni, et al.
Published: (2023-09-01) -
Amyloid-β and heart failure in Alzheimer’s disease: the new vistas
by: Hayder M. Al-Kuraishy, et al.
Published: (2025-02-01) -
CD22 modulation alleviates amyloid β-induced neuroinflammation
by: Yu Dong Mai, et al.
Published: (2025-02-01)